Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Early CMC Strategies to Support Late-Stage Success | Contract Pharma

What are you searching for?

Sign in

Early CMC Strategies to Support Late-Stage Success

Focus on a good strategy for early drug product CMC development is critical for commercial success. A well-structured, forward-looking, and phase-appropriate CMC development strategy, including risk assessments and mitigation plans at various stages, is crucial for avoiding late-stage roadblocks, dead-ends, and rework. Good decisions in early CMC development can provide flexibility for the clinic, faster and lower cost development, and a more streamlined commercial manufacturing process that provides better results and lower unit conversion costs.  

Learning Objectives: 

  • Formulation mindset for clinical flexibility and process scalability 
  • Analytical approaches to reduce re-validation and workload 
  • The importance of early-stage CMC risk assessment

Speakers:

Dr. Neha Shah
Director, Product Development – Societal™ CDMO

Dr. Kiran Pedada
Associate Director, Analytical Development – Societal™ CDMO

Register Now!
PRESENTED BY:
Warning: Undefined variable $featured_post in /var/www/html/wp-content/themes/RodmanMediaCore/single-webinar.php on line 216 Warning: Attempt to read property "ID" on null in /var/www/html/wp-content/themes/RodmanMediaCore/single-webinar.php on line 216